Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo.
Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo.
复制标题
DOI:
10.1016/j.apsb.2021.07.027
复制
发表时间:
2021-12
期刊:
影响因子:
--
通讯作者:
Yu AM
中科院分区:
文献类型:
--
作者:
Deng L;Petrek H;Tu MJ;Batra N;Yu AX;Yu AM
With the understanding of microRNA (miRNA or miR) functions in tumor initiation, progression, and metastasis, efforts are underway to develop new miRNA-based therapies. Very recently, we demonstrated effectiveness of a novel humanized bioengineered miR-124-3p prodrug in controlling spontaneous lung metastasis in mouse models. This study was to investigate the molecular and cellular mechanisms by which miR-124-3p controls tumor metastasis. Proteomics study identified a set of proteins selectively and significantly downregulated by bioengineered miR-124-3p in A549 cells, which were assembled into multiple cellular components critical for metastatic potential. Among them, plectin (PLEC) was verified as a new direct target for miR-124-3p that links cytoskeleton components and junctions. In miR-124-3p-treated lung cancer and osteosarcoma cells, protein levels of vimentin, talin 1 (TLN1), integrin beta-1 (ITGB1), IQ motif containing GTPase activating protein 1 (IQGAP1), cadherin 2 or N-cadherin (CDH2), and junctional adhesion molecule A (F11R or JAMA or JAM1) decreased, causing remodeling of cytoskeletons and disruption of cell–cell junctions. Furthermore, miR-124-3p sharply suppressed the formation of focal adhesion plaques, leading to reduced cell adhesion capacity. Additionally, efficacy and safety of biologic miR-124-3p therapy was established in an aggressive experimental metastasis mouse model in vivo. These results connect miR-124-3p−PLEC signaling to other elements in the control of cytoskeleton, cell junctions, and adhesion essential for cancer cell invasion and extravasation towards metastasis, and support the promise of miR-124 therapy. The antimetastatic activity of bioengineered miR-124-3p is attributable to selective downregulation of proteins underlying multiple cellular components, including cytoskeleton, cell junctions, and focal adhesion, critical for invasion and extravasation.
登录
查看更多内容
影响因子:
64.8
作者:
Baek, Daehyun;Villen, Judit;Shin, Chanseok;Camargo, Fernando D.;Gygi, Steven P.;Bartel, David P.
通讯作者:
Bartel, David P.
DOI:
10.1016/j.apsb.2016.02.001
发表时间:
2016-07
期刊:
Acta pharmaceutica Sinica. B
影响因子:
--
作者:
Ha D;Yang N;Nadithe V
通讯作者:
Nadithe V
影响因子:
11.2
作者:
Bader AG;Brown D;Winkler M
通讯作者:
Winkler M
影响因子:
64.5
作者:
Hatziapostolou M;Polytarchou C;Aggelidou E;Drakaki A;Poultsides GA;Jaeger SA;Ogata H;Karin M;Struhl K;Hadzopoulou-Cladaras M;Iliopoulos D
通讯作者:
Iliopoulos D
DOI:
10.1016/j.apsb.2020.10.005
发表时间:
2020-11
期刊:
Acta pharmaceutica Sinica. B
影响因子:
--
作者:
Charbe NB;Amnerkar ND;Ramesh B;Tambuwala MM;Bakshi HA;Aljabali AAA;Khadse SC;Satheeshkumar R;Satija S;Metha M;Chellappan DK;Shrivastava G;Gupta G;Negi P;Dua K;Zacconi FC
通讯作者:
Zacconi FC